{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:58:20Z","timestamp":1791845900516,"version":"4.3.4"},"reference-count":27,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T00:00:00Z","timestamp":1658361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Background: In chronic obstructive pulmonary disease (COPD), inhaled corticosteroids (ICSs) are recommended for use by patients with frequent exacerbations and blood eosinophilia. However, ICSs are often inappropriately prescribed and overused. COPD studies have reported an increased risk of tuberculosis among ICS users. This study aimed to compare the risk of tuberculosis according to the different ICS components. Methods: This study was conducted using a nationwide, population-based cohort. Patients newly diagnosed with COPD between 2005 and 2018, and treated with either fluticasone propionate or budesonide, were selected. The patients were followed up until the development of tuberculosis. Results: After propensity score matching, 16,514 fluticasone propionate and 16,514 budesonide users were identified. The incidence rate of tuberculosis per 100,000 person-years was 274.73 for fluticasone propionate and 214.18 for budesonide. The hazard ratio of tuberculosis in fluticasone propionate compared with budesonide was 1.28 (95% confidence interval 1.05\u20131.60). The risk of tuberculosis for fluticasone propionate increased with higher ICS cumulative doses: 1.01 (0.69\u20131.48), 1.16 (0.74\u20131.81), 1.25 (0.79\u20131.97), and 1.82 (1.27\u20132.62) from the lowest to highest quartiles, respectively. Conclusion: Fluticasone propionate is associated with a higher risk of tuberculosis than budesonide. ICS components can differently affect the risk of tuberculosis in patients with COPD.<\/jats:p>","DOI":"10.3390\/jpm12071189","type":"journal-article","created":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T10:36:56Z","timestamp":1658399816000},"page":"1189","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Risk of Tuberculosis Caused by Fluticasone Propionate versus Budesonide in Chronic Obstructive Pulmonary Disease: A Nationwide Population-Based Study"],"prefix":"10.3390","volume":"12","author":[{"given":"Iseul","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunmin","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2576-9062","authenticated-orcid":false,"given":"Se Hwa","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Yonsei University Wonju College of Medicine, Wonju 26426, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2051-0671","authenticated-orcid":false,"given":"Min-Seok","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seok Jeong","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suk Joong","family":"Yong","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5461-6770","authenticated-orcid":false,"given":"Won-Yeon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1763-5366","authenticated-orcid":false,"given":"Sang-Ha","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Ho","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju 26426, Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,7,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"47","DOI":"10.26719\/emhj.18.014","article-title":"Global prevalence of chronic obstructive pulmonary disease: Systematic review and meta-analysis","volume":"25","author":"Varmaghani","year":"2019","journal-title":"East Mediterr. Health J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4046\/trd.2020.0109","article-title":"Direct switch from tiotropium to indacaterol\/glycopyrronium in chronic obstructive pulmonary disease patients in Korea","volume":"84","author":"Lee","year":"2021","journal-title":"Tuberc. Respir. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4046\/trd.2020.0026","article-title":"Blood eosinophil counts in chronic obstructive pulmonary disease: A biomarker of inhaled corticosteroid effects","volume":"83","author":"Singh","year":"2020","journal-title":"Tuberc. Respir. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s12931-019-1130-y","article-title":"Evaluation of exacerbations and blood eosinophils in UK and US COPD populations","volume":"20","author":"Vogelmeier","year":"2019","journal-title":"Respir. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.2147\/COPD.S123643","article-title":"An evaluation of early medication use for COPD: A population-based cohort study","volume":"11","author":"Falk","year":"2016","journal-title":"Int. J. Chron. Obstr. Pulm. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s11606-019-05461-1","article-title":"Overuse and misuse of inhaled corticosteroids among veterans with COPD: A cross-sectional study evaluating targets for de-implementation","volume":"35","author":"Griffith","year":"2020","journal-title":"J. Gen. Intern. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3109\/15412555.2015.1081162","article-title":"Association of inhaled corticosteroids with incident pneumonia and mortality in COPD patients; systematic review and meta-analysis","volume":"13","author":"Festic","year":"2016","journal-title":"COPD"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.2147\/COPD.S269637","article-title":"Intraclass difference in pneumonia risk with fluticasone and budesonide in COPD: A systematic review of evidence from direct-comparison studies","volume":"15","author":"Lodise","year":"2020","journal-title":"Int. J. Chron. Obstr. Pulm. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2147\/COPD.S207775","article-title":"Withdrawal of inhaled corticosteroids in COPD patients: Rationale and algorithms","volume":"14","author":"Avdeev","year":"2019","journal-title":"Int. J. Chron. Obstr. Pulm. Dis."},{"key":"ref_10","first-page":"799","article-title":"Data resource profile: The national health information database of the National Health Insurance Service in South Korea","volume":"46","author":"Kim","year":"2017","journal-title":"Int. J. Epidemiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/crj.13305","article-title":"Chronic obstructive pulmonary disease research by using big data","volume":"15","author":"Rhee","year":"2021","journal-title":"Clin. Respir. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.2147\/COPD.S143656","article-title":"Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD","volume":"12","author":"Janson","year":"2017","journal-title":"Int. J. Chron. Obstr. Pulm. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/thoraxjnl-2012-203175","article-title":"Use of inhaled corticosteroids and the risk of tuberculosis","volume":"68","author":"Lee","year":"2013","journal-title":"Thorax"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1177\/1753465813480550","article-title":"Inhaled corticosteroids and the increased risk of pneumonia","volume":"7","author":"Marzoratti","year":"2013","journal-title":"Ther. Adv. Respir. Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1378\/chest.13-2137","article-title":"Use of inhaled corticosteroids in patients with COPD and the risk of TB and influenza: A systematic review and meta-analysis of randomized controlled trials","volume":"145","author":"Dong","year":"2014","journal-title":"Chest"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1164\/rccm.201007-1099OC","article-title":"Inhaled corticosteroids and risk of tuberculosis in patients with respiratory diseases","volume":"183","author":"Brassard","year":"2011","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Wu, M.F., Jian, Z.H., Huang, J.Y., Jan, C.F., Nfor, O.N., Jhang, K.M., Ku, W.Y., Ho, C.C., Lung, C.C., and Pan, H.H. (2016). Post-inhaled corticosteroid pulmonary tuberculosis and pneumonia increases lung cancer in patients with COPD. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2838-4"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.2147\/COPD.S209273","article-title":"Inhaled corticosteroids and risk of tuberculosis in patients with obstructive lung diseases: A systematic review and meta-analysis of non-randomized studies","volume":"14","author":"Castellana","year":"2019","journal-title":"Int. J. Chron. Obstr. Pulm. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1801219","DOI":"10.1183\/13993003.01219-2018","article-title":"Inhaled corticosteroids in COPD: Friend or foe?","volume":"52","author":"Agusti","year":"2018","journal-title":"Eur. Respir. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1080\/15412555.2020.1787369","article-title":"Risk of pneumonia with different inhaled corticosteroids in COPD patients: A meta-analysis","volume":"17","author":"Zhang","year":"2020","journal-title":"COPD"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1700037","DOI":"10.1183\/13993003.00037-2017","article-title":"The risk of mycobacterial infections associated with inhaled corticosteroid use","volume":"50","author":"Brode","year":"2017","journal-title":"Eur. Respir. J."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Huang, T.M., Kuo, K.C., Wang, Y.H., Wang, C.Y., Lai, C.C., Wang, H.C., Chen, L., and Yu, C.J. (2020). Risk of active tuberculosis among COPD patients treated with fixed combinations of long-acting beta2 agonists and inhaled corticosteroids. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-05440-6"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2000351","DOI":"10.1183\/13993003.00351-2020","article-title":"Withdrawal of inhaled corticosteroids in COPD: A European Respiratory Society guideline","volume":"55","author":"Chalmers","year":"2020","journal-title":"Eur. Respir. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.pupt.2007.08.005","article-title":"Do airway clearance mechanisms influence the local and systemic effects of inhaled corticosteroids?","volume":"21","author":"Wollmer","year":"2008","journal-title":"Pulm. Pharmacol. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.2147\/COPD.S172240","article-title":"Inhaled corticosteroids for chronic obstructive pulmonary disease: What is their role in therapy?","volume":"13","author":"Tashkin","year":"2018","journal-title":"Int. J. Chron. Obstr. Pulm. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1034\/j.1398-9995.1999.00087.x","article-title":"Fluticasone and budesonide inhibit cytokine release in human lung epithelial cells and alveolar macrophages","volume":"54","author":"Ek","year":"1999","journal-title":"Allergy"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1165\/ajrcmb.20.4.3265","article-title":"Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids","volume":"20","author":"Atsuta","year":"1999","journal-title":"Am. J. Respir. Cell Mol. Biol."}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/12\/7\/1189\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:55:29Z","timestamp":1760140529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/12\/7\/1189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,21]]},"references-count":27,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2022,7]]}},"alternative-id":["jpm12071189"],"URL":"https:\/\/doi.org\/10.3390\/jpm12071189","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,21]]}}}